CJC-1295 DAC (2 mg) + Ipamorelin (5 mg) — 4-Week Stack
This stack pairs CJC-1295 DAC with Ipamorelin for complementary support of growth hormone (GH) activity. CJC-1295 DAC provides a long-acting baseline, while Ipamorelin delivers short, controlled pulses—together supporting recovery, lean body composition, sleep quality, and healthy aging.
Key Benefits
- Sustained GH support from CJC-1295 DAC
- Precise, pulsatile GH release from Ipamorelin
- Supports recovery, tissue repair, and body composition
- May improve sleep quality, energy, and training capacity
- Flexible schedules: weekly + daily injections
Overview
CJC-1295 DAC (a GHRH analog) has an extended half-life, enabling once- or twice-weekly injections for steady baseline GH stimulation. Ipamorelin (a selective GHRP) provides controlled GH pulses without significant effects on cortisol or prolactin. Stacking them offers a balanced approach that aligns with a more natural release pattern.
Quickstart Highlights
- CJC-1295 DAC: 1–2 mg per week (1–2 injections); advanced up to 3 mg/week
- Ipamorelin: 300–500 mcg daily (once daily or split into 2 doses)
- Cycle Length: 4–8 weeks typical; up to 12 weeks with breaks
- Reconstitution: Reconstitute each vial with 2 ml bacteriostatic water
- Storage: Lyophilized at −20 °C; reconstituted at 2–8 °C
Dosing & Reconstitution Guide
CJC-1295 DAC (2 mg vial)
- Recombine: 2 ml bac water → 1 mg/ml
- Weekly range: 1–2 mg total (1–2 injections)
- Advanced: up to 3 mg/week split in 2–3 injections
- Volume cues: 1 mg = 1.0 ml (100 u); 0.5 mg = 0.5 ml (50 u)
Ipamorelin (5 mg vial)
- Recombine: 2 ml bac water → 2,500 mcg/ml
- Volumes: 300 mcg = 0.12 ml (12 u); 400 mcg = 0.16 ml (16 u); 500 mcg = 0.20 ml (20 u)
- Use: 1 daily injection (morning or pre-bed); advanced users may split into 2 injections
Protocol Overview
- Goal: Enhanced GH activity for recovery, composition, and healthy aging
- Schedule: CJC-1295 DAC 1–3× weekly; Ipamorelin 1–2× daily
- Method: Subcutaneous injection (rotate sites)
- Note: Reconstitute each peptide separately; do not mix in the same syringe
- Cycle: 4–8 weeks typical; reassess before extending to 12 weeks
Usage Notes (Recombine & Storage)
- Add bac water slowly along the vial wall and swirl gently (do not shake)
- Label with date; refrigerate reconstituted vials at 2–8 °C; aim to use within 14–28 days
- Use new sterile syringes; keep injection volumes in the practical 10–60 u range
What’s in the Box — 4-Week Kit
- 4 × CJC-1295 DAC 2 mg lyophilized vials
- 4 × Ipamorelin 5 mg lyophilized vials
- 8 × 2 ml sterile bacteriostatic water vials (one per peptide vial)
Why Choose EU Pharmaceuticals?
EU Pharmaceuticals delivers purity, potency, and consistency. Each vial is identity-verified and paired with clear, practical guidance so your stack is simple, accurate, and dependable.
For laboratory, educational, and research use only. Not for human or veterinary use, ingestion, diagnostic, or therapeutic purposes. No medical claims are made or implied. Buyer is responsible for proper handling, storage, and compliance with all laws.
CJC-1295 DAC (2 mg) + Ipamorelin (5 mg) — 4-Week Stack
-
$299.00
Tags: CJC-1295 DAC, Ipamorelin, peptide stack, GH support, recovery, body composition, sleep support, anti-aging, 4-week kit

